NDC 66343-074

Emvita 25

Cerebrum, Lobelia Inflata, Mag Carb, Conium, Lycopodium, Plumb Met

Emvita 25 is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Rubimed Ag. The primary component is Sus Scrofa Cerebrum; Lobelia Inflata; Magnesium Carbonate; Conium Maculatum Flowering Top; Lycopodium Clavatum Spore; Lead.

Product ID66343-074_b96fb753-1271-d3ea-e053-2a95a90a6d31
NDC66343-074
Product TypeHuman Otc Drug
Proprietary NameEmvita 25
Generic NameCerebrum, Lobelia Inflata, Mag Carb, Conium, Lycopodium, Plumb Met
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2019-06-03
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRUBIMED AG
Substance NameSUS SCROFA CEREBRUM; LOBELIA INFLATA; MAGNESIUM CARBONATE; CONIUM MACULATUM FLOWERING TOP; LYCOPODIUM CLAVATUM SPORE; LEAD
Active Ingredient Strength21 [hp_X]/50mL; [hp_M]/50mL; [hp_M]/50mL; [hp_C]/50mL; [hp_X]/50mL; [hp_X]/50mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 66343-074-50

50 mL in 1 BOTTLE (66343-074-50)
Marketing Start Date2019-06-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66343-074-50 [66343007450]

Emvita 25 LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-06-03

Drug Details

Active Ingredients

IngredientStrength
SUS SCROFA CEREBRUM21 [hp_X]/50mL

OpenFDA Data

SPL SET ID:88ff0343-316c-44f6-bb31-4d0384546b36
Manufacturer
UNII

NDC Crossover Matching brand name "Emvita 25" or generic name "Cerebrum, Lobelia Inflata, Mag Carb, Conium, Lycopodium, Plumb Met"

NDCBrand NameGeneric Name
66343-037Emvita 25Conium Maculatum Flowering Top, Magnesium Carbonate, Apomorphine Hydrochloride, Lead, Lycopodium Clavatum Spore, and Sus Scrofa Cerebellum
66343-074Emvita 25Cerebrum, Lobelia inflata, Mag carb, Conium, Lycopodium, Plumb met
66343-112Emvita 25Cerebrum, Conium, Lobelia inflata, Lycopodium, Mag carb, Plumb met

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.